Evidence map›Paper›PMID 36474983›Full record

ReviewOsteoarthritis and cartilage open2021

Osteoarthritis Research Society International (OARSI): Past, present and future.

Ali Mobasheri, Gun-Il Im, Jeffrey N Katz, John Loughlin, Virginia B Kraus, Linda J Sandell, Francis Berenbaum, Steve Abramson, Martin Lotz, Marc Hochberg and 5 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Osteoarthritis and cartilage open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ali MobasheriResearch Unit of Medical Imaging, Physics and Technology, Faculty of Medicine, University of Oulu, Oulu, Finland.
Gun-Il ImDongguk University, Goyang, South Korea.
Jeffrey N KatzBrigham and Women's Hospital, Harvard Medical School and Harvard Chan School of Public Health, Boston, MA, United States.
John LoughlinNewcastle University, Biosciences Institute, Newcastle Upon Tyne, United Kingdom.
Virginia B KrausDuke University School of Medicine, Durham, NC, USA.
Linda J SandellWashington University, St. Louis, MO, USA.
Francis BerenbaumDepartment of Rheumatology, Sorbonne Université, INSERM CRSA, AP-HP Hopital Saint Antoine, Paris, France.
Steve AbramsonNew York University Langone Orthopedic Center, New York, NY, USA.
Martin LotzThe Scripps Research Institute, La Jolla, CA, USA.
Marc HochbergDepartment of Medicine, Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.
Jean-Pierre PelletierOsteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, Quebec, Canada.
Henning MadryDepartment of Orthopaedic Surgery and Center of Experimental Orthopaedics, Saarland University Medical Center, Homburg, Germany.
Joel A BlockDepartment of Internal Medicine, Division of Rheumatology, Rush Medical College, Chicago, IL, USA.
L Stefan LohmanderDepartment of Clinical Sciences, Orthopaedics, Faculty of Medicine, Lund University, Lund, Sweden.
Roy D AltmanRonald Reagan UCLA Medical Center, Los Angeles, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We provide a detailed account of the origin and establishment of the Osteoarthritis Research Society International (OARSI) and celebrate its history from inception to the current day. We discuss the mission, vision and strategic objectives of OARSI and how these have developed and evolved over the last 3 decades. We celebrate the achievements of the society as we approach its 30th birthday, honor the entire presidential line and respectfully pay tribute to the past presidents who are no longer with us. We reflect on the strong foundations of our society, OARSI's efforts to disseminate understanding of the health, disability and economic burdens of osteoarthritis (OA) to policymakers, and the exciting initiatives to make the society inclusive and international. We thank our corporate and industrial sponsors, who have supported us over many years, without whom our annual congresses would not have been possible. We celebrate our longstanding strategic partnership with our publisher, Elsevier, and the successful launch of our new journal Osteoarthritis and Cartilage Open, the most significant new development in our dissemination toolbox. For the first time in the history of the organization, our annual congress was cancelled in April 2020 and the 2021 meeting will be virtual. Despite the numerous challenges posed by the ongoing COVID-19 pandemic and the need to adapt quickly to a rapidly changing landscape, we must remain optimistic about the future. We will take advantage of new exciting opportunities to advance our mission and vision to enhance the quality of life of persons with OA.

Indexed as

COVID-19HistoryMissionOARSIOsteoarthritis (OA)Strategic objectivesTreatment guidelinesVision

Identifiers

PMID36474983
PMCPMC9718339

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.